Anti-inflammatory Pharmacology Notes
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Drugs:
- Ibuprofen (Advil, Motrin)
- Ketorolac (Toradol)
- Meloxicam (Mobic)
- Naproxen (Aleve)
- Indomethacin
- Aspirin
- Mechanism of Action (MOA): Inhibits cyclooxygenase (COX) one and two, which inhibits prostaglandin production, leading to reduced inflammation. Also reduces the protective lining of the stomach.
- COX Effects Breakdown:
- COX 1: Supports the stomach lining, kidneys, platelet aggregation, and promotes vasodilation.
- COX 2: Pro-inflammatory.
- Indications:
- Anti-inflammatory (e.g., rheumatoid arthritis, gout).
- Analgesia (pain relief).
- Antipyretic (fever reduction).
- Aspirin: Specifically used for suppression of platelet aggregation; used for prevention of cardiovascular events.
- Aspirin should be stopped before major surgery and childbirth due to its effects on platelet aggregation.
- Black Box Warning:
- GI bleeding.
- Adverse cardiac events.
- Prescription Requirements: Meloxicam, indomethacin, and ketorolac are available by prescription only.
- Side Effects/Adverse Effects (SE/AE):
- GI bleeding.
- Nephrotoxicity (kidney damage).
- Hepatotoxicity (liver damage).
- Tinnitus (ringing in the ears) - specifically associated with aspirin.
- Aspirin and Children: Aspirin is not to be used in children under 18 years old due to the risk of Reye’s Syndrome.
- Routes of Administration: NSAIDs are available through multiple different routes with varying onsets of action.
NSAIDs – COX 2 Inhibitors
- Drug:
- MOA: Inhibits COX 2, reducing prostaglandin production and inflammation.
- Indication: Anti-inflammatory, particularly in conditions like rheumatoid arthritis (RA).
- Alternative: Considered as an alternative anti-inflammatory due to increased risk of adverse cardiovascular events with non-selective NSAIDs.
- GI Effects: Lower risk of adverse GI effects compared to non-selective NSAIDs.
Glucocorticoids / Corticosteroids
- Drugs:
- Hydrocortisone
- Prednisone
- Methylprednisolone
- Dexamethasone
- Betamethasone
- MOA:
- Suppresses inflammation by inhibiting multiple inflammatory cytokines.
- Suppresses immune response: reduces leukocyte function.
- Suppresses adrenal function via negative feedback.
- Indications:
- Adrenocortical insufficiency.
- Addison's disease.
- Inflammation.
- Immune suppression.
- Nausea.
- Specific conditions: gout, asthma, COVID-19, inflammatory bowel disease (IBD), allergies, cancers.
- Side Effects/Adverse Effects (SE/AE):
- Immunosuppression.
- Hyperglycemia (high blood sugar).
- Hypertension (high blood pressure).
- Osteoporosis (bone thinning).
- Mood swings.
- Weight gain.
- Sodium and fluid retention.
- Peptic ulcer disease (PUD).
- Abnormal fat deposits (Cushing’s syndrome).
- Administration: Preferential use of select steroids with a local effect versus a systemic effect (e.g., intranasal vs. oral).
- Available topically, intranasally, via inhalation, orally, and via injection.
- Tapering: Steroids must always be tapered when discontinued to avoid adrenal insufficiency.
- Drug Interactions: Increased risk of adverse effects if given with NSAIDs.
- Monitoring: Monitor bone density with long-term use; encourage calcium and vitamin D supplementation.
- Contraindications: Avoided in patients with an active infection due to immunosuppressive effects.
Serotonin 5-HT Agonists (Triptans)
- Drugs:
- Sumatriptan (Imitrex)
- Zolmitriptan
- Rizatriptan
- MOA: Cerebral vasoconstriction and decreases perivascular inflammation.
- Indications: Acute cluster headache and acute migraines.
- Side Effects/Adverse Effects (SE/AE): Common complaint is a vague feeling of chest pressure or heaviness.
- Administration: Taken upon the onset of migraine (aura).
- Use: First-line agent for acute migraines.
- Rebound Headaches: Can cause rebound headaches if taken in excess of twice per week or nine times per month.
- Pregnancy: Unknown safety in pregnancy – not recommended as first line in pregnancy.
- Serotonin Syndrome: Can cause serotonin syndrome if taken with other serotonin medications.
- Symptoms include agitation, confusion, fever, tachycardia, hypertension, hyperreflexia, tremors.
- Contraindications: Contraindicated in those with cardiac disease or uncontrolled hypertension.
- Overdose Treatment: Overdose treated with a beta-adrenergic antagonist.
Migraine Treatment
- Acute Treatment:
- Ergot alkaloids (e.g., ergotamine).
- CGRP receptor antagonists (e.g., rimegepant, ubrogepant).
- Prevention (Prophylaxis):
- Beta-blockers (e.g., propranolol).
- SNRIs (e.g., venlafaxine).
- TCAs (e.g., amitriptyline).
- Anti-epileptics (e.g., topiramate, valproic acid).
- CGRP monoclonal antibodies (e.g., erenumab, fremanezumab).